SUMMA RX LABORATORIES INC
10QSB, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10QSB, 2000-09-26
Next: SUMMA RX LABORATORIES INC, 10KSB40, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-QSB
FOR THE QUARTER ENDED JULY 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-QSB FOR THE QUARTER ENDED JULY 31, 1999.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               JUL-31-1999
<CASH>                                         114,324
<SECURITIES>                                         0
<RECEIVABLES>                                  388,857
<ALLOWANCES>                                    74,150
<INVENTORY>                                    227,168
<CURRENT-ASSETS>                               738,734
<PP&E>                                       1,672,273
<DEPRECIATION>                                 610,020
<TOTAL-ASSETS>                               1,803,148
<CURRENT-LIABILITIES>                          726,935
<BONDS>                                        570,000
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                     474,755
<TOTAL-LIABILITY-AND-EQUITY>                 1,803,148
<SALES>                                        776,858
<TOTAL-REVENUES>                               776,858
<CGS>                                          611,387
<TOTAL-COSTS>                                  801,664
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,569
<INCOME-PRETAX>                               (43,375)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (43,375)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (43,375)
<EPS-BASIC>                                      (.01)
<EPS-DILUTED>                                    (.01)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission